BioRestorative Therapies Announces Reverse Stock Split
BioRestorative Therapies' board approved a 1-for-20 reverse stock split, effective 4:30 PM ET on September 7, 2026, with split-adjusted trading on Nasdaq beginning September 8 under the same BRTX symbol and a new CUSIP. Shares outstanding fall from 27,622,556 to roughly 1,381,128, and authorized shares are cut proportionately from 1.5 billion to 75 million; fractional shares are rounded up and options/warrants adjust proportionately. The split is expressly aimed at regaining compliance with Nasdaq's $1.00 minimum bid price rule (Listing Rule 5550(a)(2)) — a bearish signal for a micro-cap clinical-stage biotech whose lead asset BRTX-100 is still in Phase 2.
Key figures
- New cusip
- 090655705
- Par value
- $0.0001
- Effective datetime
- 2026-09-07T16:30 ET
- Reverse split ratio
- 1-for-20
- Authorized shares pre split
- 1500000000
- Authorized shares post split
- 75000000
- Shares outstanding pre split
- 27622556
- Split adjusted trading start
- 2026-09-08
- Shares outstanding post split
- 1381128
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.